Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2021-03-04

FDA Approved: ROXICODONE — Supplemental Application (SpecGx LLC)

View source ↗

Summary

FDA approved a supplemental application for Roxicodone (oxycodone hydrochloride) submitted by SpecGx LLC.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • ROXICODONE (OXYCODONE HYDROCHLORIDE)

Snippet

SUPPL AP for ROXICODONE (OXYCODONE HYDROCHLORIDE)